Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 37% ± 17% | |
microglial cell | 12 studies | 59% ± 15% | |
glutamatergic neuron | 10 studies | 45% ± 23% | |
fibroblast | 9 studies | 28% ± 8% | |
astrocyte | 9 studies | 30% ± 15% | |
smooth muscle cell | 8 studies | 35% ± 9% | |
GABAergic neuron | 8 studies | 61% ± 18% | |
adipocyte | 7 studies | 31% ± 10% | |
oligodendrocyte precursor cell | 7 studies | 24% ± 9% | |
macrophage | 7 studies | 32% ± 15% | |
endothelial cell of lymphatic vessel | 6 studies | 35% ± 10% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
vein endothelial cell | 4 studies | 47% ± 16% | |
interneuron | 4 studies | 66% ± 17% | |
neuron | 3 studies | 37% ± 22% | |
GABAergic interneuron | 3 studies | 46% ± 10% | |
retina horizontal cell | 3 studies | 31% ± 15% | |
endothelial cell of vascular tree | 3 studies | 25% ± 5% | |
pericyte | 3 studies | 37% ± 5% | |
mesothelial cell | 3 studies | 25% ± 8% | |
myeloid cell | 3 studies | 41% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1467.02 | 244 / 245 | 94% | 7.53 | 472 / 502 |
esophagus | 98% | 1101.46 | 1417 / 1445 | 92% | 8.54 | 169 / 183 |
intestine | 99% | 1253.98 | 959 / 966 | 91% | 6.30 | 477 / 527 |
lung | 100% | 2076.54 | 576 / 578 | 90% | 6.28 | 1040 / 1155 |
adrenal gland | 100% | 1860.69 | 258 / 258 | 90% | 10.74 | 206 / 230 |
kidney | 98% | 1066.93 | 87 / 89 | 89% | 9.24 | 802 / 901 |
breast | 99% | 1270.64 | 456 / 459 | 83% | 4.64 | 928 / 1118 |
brain | 78% | 671.69 | 2048 / 2642 | 100% | 20.01 | 704 / 705 |
thymus | 99% | 815.45 | 644 / 653 | 78% | 8.57 | 472 / 605 |
bladder | 100% | 1649.10 | 21 / 21 | 69% | 4.06 | 346 / 504 |
stomach | 79% | 671.89 | 285 / 359 | 89% | 7.75 | 255 / 286 |
ovary | 99% | 898.55 | 179 / 180 | 67% | 4.37 | 290 / 430 |
uterus | 100% | 1012.27 | 170 / 170 | 61% | 5.58 | 279 / 459 |
skin | 98% | 1194.65 | 1766 / 1809 | 61% | 5.46 | 290 / 472 |
pancreas | 59% | 264.61 | 192 / 328 | 97% | 10.40 | 172 / 178 |
adipose | 100% | 1750.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3671.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1028.96 | 833 / 861 | 0% | 0 | 0 / 0 |
spleen | 96% | 623.32 | 231 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 11.13 | 73 / 80 |
muscle | 91% | 915.23 | 732 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 3.44 | 29 / 45 |
liver | 17% | 74.63 | 39 / 226 | 44% | 3.21 | 178 / 406 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.77 | 17 / 29 |
peripheral blood | 51% | 307.11 | 473 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | SH3RF3 |
Protein name | E3 ubiquitin-protein ligase SH3RF3 (EC 2.3.2.27) (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4) |
Synonyms | SH3MD4 POSH2 |
Description | FUNCTION: Has E3 ubiquitin-protein ligase activity. . |
Accessions | ENST00000309415.8 Q8TEJ3 |